Skip to main content

Table 1 Correlation of TAGLN2 expression in human glioma patients with different clinicopathological features. P values were determined by the Chi-square and Fisher’s exact tests

From: TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas

Variable   TAGLN2 high expression TAGLN2 low expression p value
Age ≥45 234 91 <0.001
<45 78 203
Gender Male 183 170 0.836
Female 129 124
KPS ≥80 154 151 0.005
<80 46 20
WHO grade II 49 165 <0.001
III 113 126
IV 148 4
TCGA subtype Neural 34 77 <0.001
Proneural 65 173
Classical 84 2
Mesenchymal 93 3
IDH1 status Mutant 103 324 <0.001
Wild-type 225 8
MGMT promotor Methylated 171 304 <0.001
Unmethylated 132 29
1p/19q Codeletion 38 132 <0.001
Non-codeletion 290 202
TERT expression Not expressed 113 203 <0.001
Expressed 221 130
ATRX status Mutant 49 146 <0.001
Wild-type 276 186